首頁 › 前列腺癌 › 密西根 › Grand Rapids
Grand Rapids, MI 的 前列腺癌 臨床試驗
19 項針對 前列腺癌 的研究正在 Grand Rapids（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
招募中1 期
- Start Midwest, Grand Rapids
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- START Midwest, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- BAMF Health Inc., Grand Rapids
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
招募中2/3 期
- BAMF Health, Grand Rapids
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
招募中1/2 期
- GSK Investigational Site, Grand Rapids
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- BAMF Health, Grand Rapids
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
招募中3 期
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
招募中1/2 期
- Research Site, Grand Rapids
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Grand Rapids
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- START, Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Spectrum Health at Butterworth Campus, Grand Rapids
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Grand Rapids 的其他研究
- 非小細胞肺癌44 項研究
- 大腸直腸癌40 項研究
- 癌症（所有類型）28 項研究
- 乳癌26 項研究
- 卵巢癌24 項研究
- 轉移性癌症22 項研究
- 子宮內膜癌18 項研究
- 胃癌18 項研究
- 胰臟癌18 項研究
- 黑色素瘤17 項研究
- 頭頸部鱗狀細胞癌15 項研究
- 三陰性乳癌15 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。